foxo4-dri senolytic peptide human trial 2024 2025 Development of a novel by precise disruption of FOXO4-p53 complex FOXO4-DRI regulates endothelial cell senescence
Description
Community reports suggest sleep disruption is less common with oral dosing, though no controlled comparison exists
It goes right through the nasal mucosa into the blood
Copper accumulation with very high doses is theoretical but not documented in clinical use
Recommendations are personalized and based on your health profile and medical review.
